Provision Interactive Announces New 3D Savings Center Platform
Apr 11, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., April 11, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO) today announced its new revolutionary 66-inch tall 3D Savings Center...
Paratek Presents Data from Omadacycline Clinical Development Program at ECCMID
Apr 11, 2016 11:30 am UTC| Business
Pooled analysis from Phase 2 and truncated Phase 3 studies demonstrates comparable safety and efficacy profiles for omadacycline compared with linezolid Single dose randomized trial demonstrates that omadacycline has no...
Paratek Presents Pre-Clinical Data on the Effects of Omadacycline on Clostridium Difficile
Apr 11, 2016 11:30 am UTC| Business
AMSTERDAM, Netherlands, April 11, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today presented data from two pre-clinical studies evaluating the impact of omadacycline on gastrointestinal flora, including...
Apr 11, 2016 11:17 am UTC| Business
Brooklyn, NY, April 11, 2016 -- The report examines the historical growth trajectory exhibited by the global LED lights market and juxtaposes it with the market’s current figures to provide forecasts about the market’s...
Profound Medical Corp., receives CE Mark Approval for TULSA-PRO™
Apr 11, 2016 11:10 am UTC| Business
TORONTO, April 11, 2016 -- Profound Medical Corp. (“Profound” or “Company”) (TSXV:PRN), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the company...
Baozun Releases 2015 Chairman Letter
Apr 11, 2016 11:06 am UTC| Business
SHANGHAI, China, April 11, 2016 -- Dear Shareholders: I would like to take this opportunity on behalf of everyone at Baozun to thank you all for your support over the past year. On May 21, 2015, we took Baozun...
Raptor Pharmaceutical Launches QUINSAIR™ in Europe
Apr 11, 2016 11:05 am UTC| Business
NOVATO, Calif., April 11, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its first commercial sale of QUINSAIR™ (levofloxacin inhalation solution) in Germany and Denmark. QUINSAIR is approved in the...